Golden State Wealth Management, LLC Tg Therapeutics, Inc. Transaction History
Golden State Wealth Management, LLC
- $667 Billion
- Q4 2024
A detailed history of Golden State Wealth Management, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 433 shares of TGTX stock, worth $14,449. This represents 0.0% of its overall portfolio holdings.
Number of Shares
433Holding current value
$14,449% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
347Shares Held
88MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$513 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$380 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$303 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$120 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$107 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.85B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...